Patients who receive add-on cholesterol-lowering medication, ezetimibe, soon after a heart attack have a significantly better prognosis than those who receive the drug later or not at all. The ...

A Swedish database of over 35,000 individuals found better cardiovascular outcomes when ezetimibe was added earlier to statin therapy for secondary prevention. Study authors deemed ezetimibe a ...

A concise, high-yield guide to cholesterol-lowering therapies—statins, Zetia, PCSK9 inhibitors, bempedoic acid, berberine, and key dietary tweaks—plus insights on benefits, risks, and mechanisms.

Ezetimibe is a drug that selectively inhibits cholesterol absorption and further reduces LDL-C when used in addition to statins. The ENHANCE trial is a randomized study aimed at studying the effect of ...

Q. I stopped dyeing my hair in 2018 and got new photos for my passport and driver’s license once my hair turned white. Now my hair is turning dark brown while I’m on rosuvastatin. I started this ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

NEW YORK, Jan 20 (Reuters) - Schering-Plough Corp said on Tuesday that U.S. prescriptions for the cholesterol drugs it sells with Merck & Co rose 8.7 percent in December, reclaiming most of the ground ...